170 related articles for article (PubMed ID: 33171140)
1. NPY-Y
Vázquez-León P; Ramírez-San Juan E; Marichal-Cancino BA; Campos-Rodríguez C; Chávez-Reyes J; Miranda-Páez A
Pharmacol Biochem Behav; 2020 Dec; 199():173071. PubMed ID: 33171140
[TBL] [Abstract][Full Text] [Related]
2. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.
Kask A; Rägo L; Harro J
Regul Pept; 1998 Sep; 75-76():255-62. PubMed ID: 9802417
[TBL] [Abstract][Full Text] [Related]
3. Analgesic and anxiolytic effects of [Leu
Vázquez-León P; Mendoza-Ruiz LG; Juan ER; Chamorro-Cevallos GA; Miranda-Páez A
Neuropeptides; 2017 Dec; 66():81-89. PubMed ID: 29042065
[TBL] [Abstract][Full Text] [Related]
4. NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test.
Kask A; Rägo L; Harro J
Neuroreport; 1998 Aug; 9(12):2713-6. PubMed ID: 9760107
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of cholecystokinin (CCK-8) microinjection into the ventrolateral and dorsolateral periaqueductal gray on anxiety models in Wistar rats.
Vázquez-León P; Campos-Rodríguez C; Gonzalez-Pliego C; Miranda-Páez A
Horm Behav; 2018 Nov; 106():105-111. PubMed ID: 30342011
[TBL] [Abstract][Full Text] [Related]
6. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
Schroeder JP; Olive F; Koenig H; Hodge CW
Alcohol Clin Exp Res; 2003 Dec; 27(12):1884-91. PubMed ID: 14691375
[TBL] [Abstract][Full Text] [Related]
7. Blockade of GPR55 in dorsal periaqueductal gray produces anxiety-like behaviors and evocates defensive aggressive responses in alcohol-pre-exposed rats.
Vázquez-León P; Miranda-Páez A; Calvillo-Robledo A; Marichal-Cancino BA
Neurosci Lett; 2021 Nov; 764():136218. PubMed ID: 34487839
[TBL] [Abstract][Full Text] [Related]
8. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
9. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety.
Cippitelli A; Rezvani AH; Robinson JE; Eisenberg L; Levin ED; Bonaventure P; Motley ST; Lovenberg TW; Heilig M; Thorsell A
Alcohol; 2011 Sep; 45(6):567-76. PubMed ID: 21145691
[TBL] [Abstract][Full Text] [Related]
10. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
Heilig M
Regul Pept; 1995 Oct; 59(2):201-5. PubMed ID: 8584755
[TBL] [Abstract][Full Text] [Related]
11. Galanin microinjection into the dorsal periaqueductal gray matter produces paradigm-dependent anxiolytic effects.
Soares FR; Silote GP; Almeida-Santos AF; Aguiar DC; Schenberg LC; Beijamini V
Brain Res Bull; 2016 Mar; 121():42-7. PubMed ID: 26751815
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic hyperreactivity of kappa opioid receptors in periaqueductal gray matter during alcohol withdrawal syndrome in rats.
Vázquez-León P; Miranda-Páez A; Sánchez-Castillo H; Marichal-Cancino BA
Pharmacol Rep; 2023 Oct; 75(5):1299-1308. PubMed ID: 37658980
[TBL] [Abstract][Full Text] [Related]
13. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
Kask A; Rägo L; Harro J
Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
[TBL] [Abstract][Full Text] [Related]
14. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects.
Heilig M; McLeod S; Brot M; Heinrichs SC; Menzaghi F; Koob GF; Britton KT
Neuropsychopharmacology; 1993 Jun; 8(4):357-63. PubMed ID: 8099792
[TBL] [Abstract][Full Text] [Related]
16. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats.
Badia-Elder NE; Stewart RB; Powrozek TA; Murphy JM; Li TK
Alcohol Clin Exp Res; 2003 Jun; 27(6):894-9. PubMed ID: 12824809
[TBL] [Abstract][Full Text] [Related]
17. The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism.
Morgan DG; Small CJ; Abusnana S; Turton M; Gunn I; Heath M; Rossi M; Goldstone AP; O'Shea D; Meeran K; Ghatei M; Smith DM; Bloom S
Regul Pept; 1998 Sep; 75-76():377-82. PubMed ID: 9802432
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
19. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray.
De Araújo JE; Huston JP; Brandão ML
Eur J Pharmacol; 2001 Nov; 432(1):43-51. PubMed ID: 11734186
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
